Boehringer Ingelheim swaps lab coats for AI algorithms in search for new drugs
Mixing IBM's foundation models and proprietary data to discover novel antibodies Boehringer Ingelheim is the latest pharma company to turn to AI in the hunt for new treatments and therapies....